Trials / Sponsors / Introgen Therapeutics
Introgen Therapeutics
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma Malignant Melanoma, Neoplasm Metastasis | Phase 2 | 2005-03-01 |
| Completed | Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer Breast Cancer | Phase 2 | 2002-02-01 |
| Unknown | Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone Carcinoma, Squamous Cell | Phase 3 | — |
| Unknown | Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Meth Carcinoma, Squamous Cell | Phase 3 | — |
| Completed | Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Brea Locally Advanced Breast Cancer (LABC) | Phase 2 | — |